Business Description
Adocia
ISIN : US00725J1025
Share Class Description:
ADOCY: ADRTotal Employee Number:
82Compare
Compare
Traded in other countries / regions
ADOC.FranceA89.Germany0QAI.UKADOCY.USA IPO Date
2014-05-21Description
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.94 | |||||
Equity-to-Asset | 0.05 | |||||
Debt-to-Equity | 5.97 | |||||
Debt-to-EBITDA | -0.58 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -0.48 | |||||
Beneish M-Score | -5.25 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -61.4 | |||||
3-Year EBITDA Growth Rate | -24.5 | |||||
3-Year EPS without NRI Growth Rate | -10.1 | |||||
3-Year FCF Growth Rate | 41.4 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 170.89 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.19 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.86 | |||||
Days Inventory | 124.74 | |||||
Days Sales Outstanding | 1391.04 | |||||
Days Payable | 681.61 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.1 | |||||
Shareholder Yield % | -18.24 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 46.31 | |||||
Operating Margin % | -1068.68 | |||||
Net Margin % | -1124.81 | |||||
EBITDA Margin % | -1041.83 | |||||
FCF Margin % | -455.94 | |||||
OCF Margin % | -437.86 | |||||
ROA % | -60.18 | |||||
ROIC % | -72.1 | |||||
3-Year ROIIC % | 631.97 | |||||
ROC (Joel Greenblatt) % | -504 | |||||
ROCE % | -216.57 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 54.63 | |||||
PS Ratio | 53.66 | |||||
PB Ratio | 58.61 | |||||
Price-to-Tangible-Book | 56.19 | |||||
EV-to-EBIT | -5.02 | |||||
EV-to-EBITDA | -5.19 | |||||
EV-to-Revenue | 54.05 | |||||
EV-to-Forward-Revenue | 1.27 | |||||
EV-to-FCF | -11.73 | |||||
Price-to-GF-Value | 4.96 | |||||
Price-to-Median-PS-Value | 5.49 | |||||
Earnings Yield (Greenblatt) % | -19.92 | |||||
FCF Yield % | -7.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ADOCY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adocia Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.709 | ||
| EPS (TTM) ($) | -1.045 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -61.75 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 11.8 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 11.8 - 11.8 | ||
| Shares Outstanding (Mil) | 19.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adocia Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adocia Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adocia Frequently Asked Questions
What is Adocia(ADOCY)'s stock price today?
The current price of ADOCY is $11.80. The 52 week high of ADOCY is $11.80 and 52 week low is $11.80.
When is next earnings date of Adocia(ADOCY)?
The next earnings date of Adocia(ADOCY) is .
Does Adocia(ADOCY) pay dividends? If so, how much?
Adocia(ADOCY) does not pay dividend.
Guru Commentaries on OTCPK:ADOCY
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Adocia
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers